Anti-Tumor Necrosis Factor Therapy Inhibits Lung Metastasis in an Osteosarcoma Cell Line
暂无分享,去创建一个
A. Sudo | A. Matsumine | H. Wakabayashi | S. Kato | T. Nakagawa | Y. Naito | Hiroaki Kato
[1] A. Sudo,et al. TNF inhibitor suppresses bone metastasis in a breast cancer cell line. , 2011, Biochemical and biophysical research communications.
[2] K. Utsunomiya,et al. Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells. , 2010, Biochemical and biophysical research communications.
[3] Dali Li,et al. KiSS1 suppresses TNFα‐induced breast cancer cell invasion via an inhibition of RhoA‐Mediated NF‐κB activation , 2009, Journal of cellular biochemistry.
[4] Yong Lin,et al. Tumor necrosis factor and cancer, buddies or foes? , 2008, Acta Pharmacologica Sinica.
[5] Hiroki Wakabayashi,et al. Decorin Suppresses Bone Metastasis in a Breast Cancer Cell Line , 2008, Oncology.
[6] H. Wajant,et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. , 2008, Cancer research.
[7] T. Hagemann,et al. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. , 2007, Cancer research.
[8] T. Hagemann,et al. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. , 2005, Cancer research.
[9] G. Watanabe,et al. Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55 , 2004, International journal of cancer.
[10] M. Mai,et al. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. , 2002, Cancer research.
[11] F. Balkwill. Tumor necrosis factor or tumor promoting factor? , 2002, Cytokine & growth factor reviews.
[12] F. Sim,et al. Malignant bone tumors. , 2001, Instructional course lectures.
[13] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[14] G. Kollias,et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis , 1999, Nature Medicine.
[15] C. Rüegg,et al. Clinical applications of TNF-α in cancer , 1998 .
[16] B. Scallon,et al. Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions , 1995 .
[17] B. Scallon,et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. , 1993, Molecular immunology.
[18] J. Rüschoff,et al. Enhancement of experimental metastasis by tumor necrosis factor , 1993, The Journal of experimental medicine.
[19] M. Lomicek,et al. [Malignant bone tumors]. , 1957, Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca.
[20] N. Jaffe,et al. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. , 2006, Journal of pediatric surgery.
[21] A. Montag,et al. An Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary Metastasis , 2005, Clinical & Experimental Metastasis.
[22] A. Roessner,et al. Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor α correlates with metastatic ability in a human osteosarcoma cell line , 2004, Virchows Archiv.
[23] G. Kollias,et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. , 1999, Nature medicine.
[24] C. Rüegg,et al. Clinical applications of TNF-alpha in cancer. , 1998, Current opinion in immunology.
[25] B. Scallon,et al. Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions. , 1995, Cytokine.
[26] F. Balkwill,et al. Cells secreting tumour necrosis factor show enhanced metastasis in nude mice. , 1990, European journal of cancer.